Peak6 Investments LLC Novo Cure LTD Put Options Transaction History

Peak6 Investments LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$11.83 - $24.05 $59,150 - $120,250	5,000 New	5,000 $85,000
Q1 2023 May 12, 2023	BUY	$56.44 - $118.81 $739,364 - $1.56 Million	13,100 New	13,100 $787,000
Q1 2021 May 14, 2021	SELL	$124.11 - $190.17 $3.14 Million - $4.81 Million	-25,300 Reduced 23.69%	81,500 $10.8 Million
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $17.8 Million - $27.7 Million	-158,800 Reduced 59.79%	106,800 $18.5 Million
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $9.74 Million - $18.7 Million	167,800 Added 171.57%	265,600 $29.6 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $2.71 Million - $3.53 Million	47,400 Added 94.05%	97,800 $5.8 Million
Q1 2020 May 14, 2020	SELL	$57.05 - $95.75 $1.99 Million - $3.34 Million	-34,900 Reduced 40.91%	50,400 $3.39 Million
Q4 2019 Feb 13, 2020	BUY	$68.3 - $93.8 $5.83 Million - $8 Million	85,300 New	85,300 $7.19 Million

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.